Thank you ohm20 for the detailed explanation. As a

Thank you ohm20 for the detailed explanation. As a scientific nitwit, is this more or less encouraging than your previous analysis?

I understood you thought a PD-1 inhibitor would be a good combo with leronlimab, so does this information make that more or less significant and/or more information needed?

I invested in leronlimab for cancer pre-COVID, so for my non-medical background this is one of the most encouraging information I can recall. Once MOA is proven, I would think every BP will be standing in line to submit their partnership proposal or BO offer.

Please do your own due diligence. All my posts and comments are not to be considered investment advice.